Cyclin D1 protein expression and function in human breast cancer
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Cyclin D1 is a cell‐cycle regulator essential for G 1, phase progression and a candidate proto‐oncogene implicated in pathogenesis of several human tumour types, including breast carcinomas. In spite of the accumulating genetic evidence, however, there are no data regarding abundance and properties of the cyclin D1 protein in breast cancer. We now report aberrant nuclear overexpression/accumulation of the cyclin D1 protein in about half of the 170 primary breast carcinoma specimens analyzed by monoclonal antibody immunohistochemistry, indicating that the frequency of cyclin D1 abnormalities may be considerably higher than previously deduced from DNA amplification studies. A comparison of the expression patterns in matched lesions at different stages of tumour progression revealed that the cyclin D1 protein aberration appears to reflect a relatively early event and that, when acquired by a tumour, it is maintained throughout breast cancer progression including metastatic spread. In both tumour tissues and breast cancer cell lines, the abundance of this protein shows characteristic variations consistent with a cell‐cycle oscillation and the peak levels expressed in G 1. In all 7 cell lines whose retinoblastoma (Rb) protein is mutant or complexed to SV40 T antigen, exceptionally low levels of cyclin D1 protein and mRNA were found. Antibody‐mediated and anti‐sense oligonucleotide knockout experiments demonstrate the requirement for the cell‐cycle regulatory function of cyclin D1 in breast cancer lines with single or multiple copies of the gene and reveal the absence of such a requirement in the cell lines with Rb defects. Our data are consistent with the notion that the emerging “Rb‐cyclin D1 pathway” represents a frequent target of oncogenic abnormalities in breast cancer. © 1994 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Cyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
Self-citationANIMAL CELL CYCLES AND THEIR CONTROL
Norbury, C., & Nurse, P. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.002301 · Cited by 1,274
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Pines, J., & Hunter, T. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.1.1 · Cited by 858
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 685
Expression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
Redundant cyclin overexpression and gene amplification in breast cancer cells.
Keyomarsi, K., & Pardee, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1112 · Cited by 512
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
Rosenberg, C. L., Wong, E., Petty, E. M., Bale, A. E., Tsujimoto, Y., Harris, N. L., & Arnold, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9638 · Cited by 432
Structural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma
T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., & Fung, Y.-K. T. (1988) · Science · doi:10.1126/science.3175651 · Cited by 403
Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R. J. A. M., Dickson, C., Arnold, A., & Peters, G. B. (1991) · PubMed · Cited by 371
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., & Weinstein, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9026 · Cited by 360
Characterization of a candidate bcl-1 gene.
Withers, D. A., Harvey, R. C., Faust, J. B., Melnyk, O., Carey, K., & Meeker, T. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4846 · Cited by 340
Schuuring, E., Verhoeven, E., Mooi, W. J., & Michalides, R. J. A. M. (1992) · PubMed · Cited by 317
Genomic organization, chromosomal localization, and independent expression of human cyclin D genes
Inaba, T., Matsushime, H., Valentine, M., Roussel, M. F., Sherr, C. J., & Look, A. T. (1992) · Genomics · doi:10.1016/0888-7543(92)90126-d · Cited by 257
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
Lukáš, J., Pagano, M., Stašková, Z., Draetta, G. F., & Bartek, J. (1994) · PubMed · Cited by 248
Self-citationCyclin D1 expression is regulated by the retinoblastoma protein.
Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M., & Strauss, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2945 · Cited by 235
Self-citationCellular substrates of p34cdc2 and its companion cyclin-dependent kinases
Nigg, E. A. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90011-o · Cited by 231
Motokura, T., & Arnold, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90022-5 · Cited by 189
Sewing, A., Bürger, C., Brüsselbach, S., Schalk, C., Lucibello, F. C., & Müller, R. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.545 · Cited by 160
Bartek, J., Bartkova, J., Kyprianou, N., Lalani, E. N., Staskova, Z., Shearer, M., Chang, S., & Taylor-Papadimitriou, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3520 · Cited by 150
Self-citationMotokura, T., Keyomarsi, K., Kronenberg, H. M., & Arnold, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88717-3 · Cited by 145
Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines.
Palmero, I., Holder, A. A., Sinclair, A. J., Dickson, C., & Peters, G. (1993) · PubMed · Cited by 86
Chromosome 11q13 abnormalities in human breast cancer.
Fantl, V., Smith, D., Brookes, S., Dickson, C., & Peters, G. B. (1993) · PubMed · Cited by 80
BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet, C. G., Adnane, J., Szepetowski, P., Simon, M., Jeanteur, P., Birnbaum, D., & Gaudray, P. (1990) · PubMed · Cited by 76
Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou, T., Kranenburg, O., van Dam, H., Roelen, D. L., ZANTEMA, A., Fl, H., & van der Eb, A. (1993) · PubMed · Cited by 48
Molecular pathology of the cell cycle in human cancer cells
rtek, J. R. I. B. A., aacute, Z. S. S. K., Draetta, G. F., & Lukáš, J. (1993) · Stem Cells · doi:10.1002/stem.5530110611 · Cited by 23
Cited by
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Sledge, G. W., Toi, M., Neven, P., Sohn, J., Inoue, K., Pivot, X., Burdaeva, O., Okera, M., Masuda, N., Kaufman, P. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7585 · Cited by 1,680
“50% of patients with breast cancer.(9) Cyclin D is the catalyst for CDK 4 and 6, and overactivation of CDK 4 and 6 may attenuate senescence and promote cell cycle progression.”
BackgroundThe RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“These findings appear relevant to human breast cancers where cyclin D1 is frequently overexpressed (Bartkova et al., 1994) and where low levels of p27Kip1 convey a poor prognosis (Catzavelos et al., 1997; Porter et al., 1997; Cariou et al., 1998).”
BackgroundThe protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
Metadata
- Authors
- Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-05
- Volume
- 57
- Issue
- 3
- Pages
- 353-361
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2119040192
- Cited by
- 509
- References
- 32
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.